INTRODUCTION
============

Visceral leishmaniasis (VL), also known as kala azar is a fatal vector-borne illness caused by *Leishmania donovani.* The disease remains a public health problem worldwide causing considerable morbidity and mortality. The chemotherapy of VL has been undermined by drug resistance, variable efficacy, toxicity, parenteral administration, and requirement for long courses of treatment. In India, sodium antimony gluconate (SAG) is no longer useful as a drug because more than 64% of VL patients fail to respond or promptly relapse due to development of resistance in the parasites ([@B34]). Alternative chemotherapeutic measures with amphotericin B (AMB) and its lipid formulations have severe limitations due to their toxic effects and prohibitive high cost. VL has also emerged as an opportunistic infection in individuals carrying HIV infection ([@B19]). Thus, there is an urgent need for new and promising compounds for the treatment of this debilitating disease, which mainly affects the rural population.

Essential oils (EO) are volatile mixtures of compounds obtained from spices, aromatic herbs, fruits, and flowers and have been traditionally used in folk medicine to treat several diseases. Various research groups have demonstrated that EO and their main components possess a wide spectrum of biological activities, which may be of great importance in several fields ranging from food chemistry to pharmacology and pharmaceutics. These properties have been attributed to the presence of characteristic constituents, the most abundant being the terpenoids, specially the monoterpenes and sesquiterpenes ([@B30]). EO are known to have antibacterial and antifungal properties against human pathogenic microorganisms ([@B8]). EO obtained from *Achillea millefolium* and *Ocimum basilicum* ([@B28]) exhibited toxic effects against trypanosomes, the protozoal species closely related to *Leishmania*. A plethora of studies indicate promising leishmanicidal effect of EO from various plants including *Croton cajucara* ([@B24]), *Ocimum gratissimum* ([@B38]), *Artemisia abyssinica* ([@B35]), *A. absinthium* L. ([@B36]), and *A. herba-alba* ([@B16]). *A. annua* (Asteraceae), a well-known traditional medicinal plant, has been extensively used as antimalarial and anticancer agent. EO from *A. annua* has been reported to exhibit antifungal, antibacterial ([@B11]) and acaricidal activities ([@B21]).

In this study, we demonstrated the leishmanicidal effect of EO from the leaves of *A. annua* (AALEO) on the promastigotes and amastigotes of *L. donovani* with negligible toxic effect on the host macrophages. We further established the *in vivo* efficacy of AALEO upon intraperitoneal administration to infected BALB/c mice with no impairment of hepatic and renal functions. Our results suggest that AALEO may be a source of novel agents for the treatment of VL.

MATERIALS AND METHODS {#s1}
=====================

MATERIALS
---------

Fetal bovine serum (FBS) was procured from Gibco-BRL, DMSO from SRL, methanol from Merck, limulus amebocyte lysate (LAL) kit from Pierce, Thermo Scientific and annexin V-FITC and the Apo- Direct kits from Roche Inc., Basel, Switzerland. All the other chemicals were from Sigma--Aldrich unless otherwise stated.

PARASITE CULTURE AND MAINTENANCE
--------------------------------

*Leishmania donovani* parasites (MHOM/IN/83/AG83) were maintained *in vivo* in BALB/c mice. Promastigotes were routinely cultured at 22°C in M199 medium supplemented with 10% heat inactivated FBS, penicillin (100 IU ml^-1^), streptomycin (100 μg ml^-1^). Log phase promastigotes were sub-cultured every 72--96 h, the inoculum being 2 × 10^6^ cells ml^-1^.

CELL CULTURE
------------

Cell line, RAW 264.7 were grown at 37°C in RPMI-1640 medium (pH 7.4) supplemented with 10% heat-inactivated FBS for 48--72 h in a humidified atmosphere of 5% CO~2~ and sub-cultured in fresh RPMI-1640 medium at an average density 2 × 10^5^ cells ml^-1^.

ANIMALS
-------

Female BALB/c mice, aged 6--8 weeks and weighing about 20--25 g were used in the present study. All the animals were individually housed in standard size polycarbonate cages with controlled conditions of temperature (23 ± 1°C), humidity (55 ± 10%), 12:12 h of light and dark cycles and fed with a standard pellet diet (Ashirwad Industries, Chandigarh, India) and filtered water *ad libitum* in the Central Animal House of Jamia Hamdard according to the internationally accepted principles. *A prior* approval (Ethical approval judgment number 459) was obtained from the Jamia Hamdard Animal Ethics Committee (JHAEC) for the study protocol. JHAEC is registered under the Committee for the purpose of control and supervision of experiments on animals (CPCSEA).

PLANT MATERIAL AND THE ESSENTIAL OIL
------------------------------------

Fresh *A. annua* leaves were collected from the Herbal Garden of Jamia Hamdard. The essential oil was extracted with a modified Clevenger-type apparatus (Borosilicate) by steam distillation ([@B37]). Briefly, 1 kg of the *A. annua* fresh leaves were boiled in 3 L of distilled water for 4 h. At the end of this procedure, the yield obtained was 0.6% of oil on a dry weight basis (4.2 g of *A. annua* leaves). After extraction, the essential oil obtained was carefully separated, transferred to an opaque glass vial with rubber lid and covered with aluminum foil to protect from light. The EO was stored in a refrigerator (--20°C) prior to analysis. For biological assays, EO was reconstituted aseptically to 1 mg ml^-1^ in DMSO (cell culture grade) and diluted further in culture medium to achieve a final DMSO concentration of not more than 0.2%.

GC AND GC-MS ANALYSIS OF THE ESSENTIAL OIL FROM *A. annua* LEAVES
-----------------------------------------------------------------

The chemical composition and characterization of the bio-active compounds from the essential oil of AALEO was analyzed by gas chromatography (GC) and GC-mass spectrometry (GC-MS) using a SHIMADZU QP2010 with a RTX5 MS column (30 m, film 0.25 μm, ID 0.25 mm). The temperature of the column was programmed from 45 to 270°C at 5°C min^-1^, the injector and detector temperatures for the analysis were 250°C. Helium was used as the carrier gas at a flow rate of 1.5 ml min^-1^. The identification of chemical constituents was performed on the basis of retention indices (RI) determined with reference to a homologous series of n-alkanes, under identical experimental conditions, co-injected with standards (RESTEK, 110 Benner Circle, Bellefonte, PA, USA), followed by MS library search (WILEY8.LIB and NIST08.LIB Version; [@B14]).

PROMASTIGOTE PROLIFERATION KINETICS AND GROWTH REVERSIBILITY ASSAY
------------------------------------------------------------------

Promastigotes (2 × 10^6^ cells ml^-1^) in M199 medium were incubated at 22°C with AALEO (100 μg ml^-1^) in M199 containing 10% FBS. Pentamidine at the same concentration served as the reference antileishmanial drug while 0.2% DMSO, which represented the highest concentration in the test oil was used as solvent control. Parasites in media alone were taken as control. Promastigotes were enumerated daily for 7 days in a hemocytometer under phase contrast microscope using 40X objective ([@B10]). Treated and untreated parasites after 7 days in culture, were washed and re-suspended in fresh medium, and allowed to grow for a further 4 days at 22°C. The viability of the parasites was determined microscopically to affirm the leishmanicidal effect of AALEO ([@B1]).

DETERMINATION OF PROMASTIGOTE CELLULAR MORPHOLOGY
-------------------------------------------------

Changes in the cellular morphology of parasites as a result of AALEO treatment was observed microscopically. Briefly, the promastigotes (2 × 10^6^ cells ml^-1^) were incubated at 22°C in the absence or presence of AALEO and pentamidine for 72 h at a concentration of 100 μg ml^-1^ and observed under 40X objective using a phase-contrast microscope. At least 20 microscopic fields were examined for each sample. Data were recorded using NIS-Elements imaging software ([@B20]).

DOSE-DEPENDENT EVALUATION OF ANTI-PROMASTIGOTE ACTIVITY AND DETERMINATION OF IC~50~
-----------------------------------------------------------------------------------

Promastigotes at a density of 2 × 10^6^ cells ml^-1^ were incubated in the absence and or presence of AALEO at serial three fold dilutions starting at 100 μg ml^-1^ (100, 33.33, 11.11, 3.70, 1.23, and 0.41 μg ml^-1^) for 72 h at 22°C. Pentamidine was used as a standard antileishmanial drug. The mean percentage viability was calculated as follows: (Mean cell number of treated parasites/Mean cell number of untreated parasites) X 100. The 50 % inhibitory concentration (IC~50~) i.e., the concentration that decreased the cell growth by 50 % was determined by graphical extrapolation after plotting the graph of percent (%) viability versus concentration of the drug ([@B10]).

ANTI-AMASTIGOTE ACTIVITY AND NITRITE PRODUCTION IN AN *EX-VIVO* MACROPHAGE--MODEL
---------------------------------------------------------------------------------

Macrophages from the RAW 264.7 cell line (1 × 10^6^ cells ml^-1^) were allowed to adhere to round glass cover slips in a 24-well tissue culture plate and incubated for 12 h at 37°C in a carbon dioxide incubator (5% CO~2~). After removal of the non-adherent macrophages, the cells were infected with stationary phase promastigotes using a cell to parasite ratio of 1:10 and incubated at 37°C for 24 h. The non-phagocytosed parasites were removed by washing, and the infected macrophages incubated with AALEO (0--100 μg ml^-1^) for an additional 48 h. The cover slips were fixed in methanol and giemsa-stained for microscopic evaluation (100X) of amastigote infectivity. At least 200 macrophages per cover slip were analyzed, and the concentration that decreased amastigotes by 50% (IC~50~) was determined ([@B10]).

The supernatant from control *L. donovani* infected and treated macrophages (RAW 264.7) were analyzed for nitrite content by the Griess reaction. In brief, equal volume of Griess reagent \[1% sulphanilamide and 0.1% *N*-(1-naphthyl) ethylenediamine dihydrochloride in 5% phosphoric acid\] was added to the culture supernatant and the plates were incubated for 10 min at room temperature using sodium nitrite as a standard. The absorbance at 550 nm was measured, and the concentration of nitrite was calculated by a linear regression analysis using the standard curve generated with sodium nitrite ([@B39]). All the reagents including AALEO, were free of lipopolysaccharide (0.2 ng ml^-1^ endotoxin) as determined by LAL chromogenic endotoxin quantitation kit as per the manufacturer's instructions (Pierce, Thermo Scientific).

*EX VIVO* CYTOTOXICITY ASSAY
----------------------------

To evaluate the adverse toxicity of AALEO on mammalian cells, the murine macrophage cell line (RAW 264.7) cultured in RPMI 1640 medium were exposed to increasing concentrations of AALEO (0--200 μg ml^-1^) at 37°C, 5 % CO~2~ for 48 h. Pentamidine as the reference drug, and macrophages without any treatment were taken as control. The percentage of cell viability was evaluated by MTT (3-{4,5-dimethylthiazol-2-yl}-2,5-diphenyltetrazolium bromide) assay ([@B3]).

ANALYSIS OF PHOSPHATIDYLSERINE (PS) EXTERNALIZATION
---------------------------------------------------

To visualize PS exposure, double staining with Annexin-V and PI was performed with minor modifications. Briefly, promastigotes (2 × 10^6^ cells ml^-1^) were incubated with AALEO at a concentration of 100 μg ml^-1^ for 72 h. Untreated and treated parasites were centrifuged at 3000 × *g* for 10 min, washed twice in cold PBS and the pellet was resuspended in Annexin V-FLUOS labeling solution (100 μl, containing both Annexin-V and PI), as per the manufacturer's instructions (Roche). After 15 min of incubation in the dark at 26°C, 400 μl of incubation buffer was added, mixed and acquired using a BD LSR II flow cytometer and analyzed using Deva software. Pentamidine served as the reference antileishmanial drug (100 μg ml^-1^) while parasites without any treatment were taken as control.

*IN SITU* DETECTION OF DNA FRAGMENTATION BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TdT) MEDIATED dUTP NICK-END LABELING (TUNEL) ASSAY
-------------------------------------------------------------------------------------------------------------------------------------

*In situ* detection of DNA fragments within the promastigotes was analyzed by TdT-mediated dUTP nick-end labeling (TUNEL) assay using an *in situ* cell death detection kit (Roche) according to the manufacturer's instructions. Briefly, promastigotes (2 × 10^6^ cells ml^-1^) were incubated at 22°C with AALEO (100 μg ml^-1^), pentamidine (100 μg ml^-1^) as the reference drug and with media alone as control. After 72 h, the cells were washed, fixed with 4% paraformaldehyde on ice for 1 h, washed with PBS and incubated with 3% H~2~O~2~ in methanol for 10 min at 25°C. This was followed by washing with PBS and the cells were then permeabilized with freshly prepared chilled 0.1% Triton X-100 for 5 min on ice. The cells were washed twice with PBS, after which 50 μl of reaction mixture containing TdT and FLUOS labeled dUTP was added for 1 h at 37°C, washed and finally resuspended in PBS for acquisition in a BD LSR II flow cytometer and analyzed using Deva software.

In a parallel experiment, the stained samples were visualized under a high-resolution fluorescence microscope under 10× objective, and the images captured and processed.

STUDY OF DYSKINETOPLASTIDY BY FLUORESCENCE MICROSCOPY
-----------------------------------------------------

To detect the changes in kinetoplast DNA (kDNA) of promastigotes, untreated and AALEO (100 μg ml^-1^) treated exponential-phase promastigotes (2 × 10^6^ cells ml^-1^) after 72 h were washed twice with PBS, fixed with 80% chilled ethanol and kept at 4°C for 24 h. The cells were then washed with PBS and the pellet was resuspended in 500 μl DNase-free RNase (200 μg ml^-1^) for 1 h at 37°C. The cells were stained with PI (50 μg ml^-1^) and incubated in the dark for 20 min at 4°C. An aliquot of 20 μl was taken from each sample, placed on a glass slide and observed directly under 20× objective (without fixation) under a high-resolution fluorescence microscope (Nikon). The images were processed using NIS-Elements imaging software. At least 20 microscopic fields were observed for each sample ([@B33]).

EFFECT OF AALEO ON CELL CYCLE
-----------------------------

Percentage of cells in the different phases of cell cycle was detected through flow cytometry by propidium iodide (PI) staining. Briefly, promastigotes (2 × 10^6^cells ml^-1^) were treated with AALEO (100 μg ml^-1^) for 72 h at 22°C, washed twice with PBS, fixed with 80% chilled ethanol and kept at 4°C for 24 h. The cells were then washed with PBS and the pellet resuspended in 500 μl DNase free RNase A (200 μg ml^-1^) for 1 h at 37°C. The cells were stained with PI (50 μg ml^-1^) and incubated in the dark for 20 min at 4°C. Data acquisition was carried out using BD FACS Calibur flow cytometer and analyzed using Cell Quest software ([@B22]).

MITOCHONDRIAL MEMBRANE POTENTIAL (ΔΨm) DETERMINATION
----------------------------------------------------

The mitochondrial transmembrane potential (ΔΨm) was measured using a fluorogenic cell-permeable cationic dye, JC-1 (5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbo-cyanine iodide). To analyse the changes in ΔΨm, the promastigotes after exposure to AALEO (100 μg ml^-1^) for 72 h were centrifuged, resuspended in PBS containing JC-1 (10 μg ml^-1^) and incubated at 37°C for 10 min. The cells were then analyzed by flow cytometry, BD LSR II and DEVA software. The ratio of the red/green fluorescence intensities was considered as the relative ΔΨm value ([@B25]).

ESTIMATION OF INTRACELLULAR REACTIVE OXYGEN SPECIES (ROS) LEVELS
----------------------------------------------------------------

To monitor the effect of AALEO on the generation of reactive oxygen species (ROS), late log phase promastigotes were treated with AALEO at 22°C for 72 h. The cells were washed twice with PBS and finally resuspended in 500 μl PBS, loaded with a cell permeant probe, 2, 7 dichlorodihydrofluorescein diacetate (H~2~DCFDA; 10 μM) and incubated for 30 min at 25°C. The cells were analyzed for intracellular ROS by BD LSR II flow cytometer and DEVA software ([@B15]).

*IN VIVO* EFFICACY OF AALEO AGAINST *L. donovani*
-------------------------------------------------

Female BALB/c mice (6 to 8-weeks old) were infected with stationary phase promastigotes (2 × 10^7^ per animal) through tail vein. Two months post infection, parasite burden was confirmed in two arbitrarily selected animals; after which, the mice were randomly assigned into four groups. Group-A comprised of control, infected mice without treatment (INF), vehicle control Group-B received normal saline (VC). Group-C was administered AALEO intraperitoneally (i.p.) and further divided into three subgroups (*n* = 5) that received three doses of AALEO (50, 100, 200 mg/kg body weight {b.w.}) for ten consecutive days. Group-D received the standard antileishmanial drug, AMB (5 mg/kg b.w. for 10 alternate days, intravenously {i.v.}) and served as the positive control. Ten days post treatment, mice were euthanized by CO~2~ asphyxiation, the liver and spleen parasite burdens were determined from giemsa-stained multiple impression smears and expressed as Leishman-Donovan units (LDU) that was calculated as the number of parasites per 500 nucleated cells × organ weight (mg) ([@B7]).

The percent reduction in parasite load (% protection) was calculated using the formula.
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Cure or protection correlated with a fall in hepatosplenomegaly and elimination of parasites to negligible levels.

*IN VIVO* TOXICITY ASSAY
------------------------

Hepatic and renal functions of BALB/c mice were evaluated in treated and untreated animals as described previously ([@B2]). Two-weeks post treatment, blood was drawn from the retro-orbital plexus and serum was separated by centrifugation at 5000 × *g* for 2--3 min. The serum was stored at -80°C until use. The hepatic and renal functions were assessed by measuring the levels of serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), and alkaline phosphatase (ALP), urea and creatinine using commercially available kits (Span Diagnostics Ltd.). The hepatic and renal functions were similarly evaluated in normal BALB/c mice at higher (200 mg/kg b.w.) dose of AALEO.

STATISTICAL ANALYSIS
--------------------

The *in vitro* experiments were performed at least in triplicate. A minimum of five mice per group was used for all *in vivo* experiments. Error bars represent the SEM.

The statistical significance of differences between the groups was determined as described in the figure legends using ANOVA followed by Tukey's test by Graph Pad Prism 5 software, and a *p-*value of \<0.05 was considered statistically significant.

RESULTS
=======

GC AND GC-MS ANALYSIS OF AALEO
------------------------------

The composition of the essential oil exhibiting leishmanicidal activity was studied by GC and GC-MS. The major chemical constituent was identified as Camphor; 52.06% (**Table [1](#T1){ref-type="table"}**); by comparison of mass spectral data, retention times (RT), and RI. The other constituents present in the essential oil were β-caryophyllene (10.95 %), 1,8-cineole (5.57 %), β-caryophyllene oxide (4.21 %), β-farnesene (3.83 %), α-copaene (2.91 %), β-cyperone (1.93 %), α-selinene (1.54 %), and *trans*-pinocarveol (1.22 %) as presented in **Table [1](#T1){ref-type="table"}**.

###### 

Phytochemical fingerprinting of AALEO by GC-MS.

  Peak     Retention time (RT)   Retention index (RI)   Area          Area%       Compound
  -------- --------------------- ---------------------- ------------- ----------- ---------------------------------------------------------------
  1        3.250                 876                    73280         0.50        β-Pinene
  2        4.549                 929                    810646        5.57        1,8-Cineole
  3        5.586                 972                    167764        1.15        o-Cymol
  4        5.683                 976                    38352         0.26        Isovaleric acid
  5        9.449                 1093                   47296         0.33        1-Octen-3-ol
  6        9.990                 1108                   41392         0.28        α-Cubebene
  7        11.028                1133                   422708        2.91        a-Copaene
  **8**    **11.672**            1149                   **7573773**   **52.06**   **Camphor**
  9        12.269                1164                   47711         0.33        3-Caren-10-al
  **10**   **13.772**            1201                   **1593527**   **10.95**   **β -Caryophyllene**
  11       14.451                1217                   38244         0.26        δ-Myrtenal
  12       15.073                1232                   177125        1.22        (E)-Pinocarveol
  13       15.308                1238                   54947         0.38        Germacrene B
  14       15.540                1243                   556838        3.83        β-Farnesene
  15       15.784                1249                   224008        1.54        α-Selinene
  16       16.035                1255                   49450         0.34        β-Chamigrene
  17       16.119                1257                   65761         0.45        g-Muurolene
  18       16.248                1260                   50529         0.35        α-Terpineol
  19       16.330                1262                   80643         0.55        Borneol
  20       16.690                1270                   165303        1.14        α-Amorphene
  21       16.965                1277                   280737        1.93        β-Cyperone
  22       17.298                1285                   41837         0.29        S (+)-Carvone
  23       17.945                1300                   78707         0.54        δ-Cadinene
  24       18.358                1310                   25951         0.18        (E)-Carveol
  25       18.636                1316                   32965         0.23        1,3-Dimethyladamantane
  26       18.761                1319                   44074         0.30        Myrtenol
  27       19.907                1347                   75486         0.52        (Z)-Carveol
  28       20.285                1356                   18366         0.13        *p*-Cymen-8-ol
  29       20.807                1368                   41234         0.28        Benzyl valerate
  30       21.408                1383                   49028         0.34        (2E)-2-Methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal
  31       22.335                1405                   20933         0.14        Vulgarone B
  32       23.518                1434                   49521         0.34        Viridiflorol
  **33**   **23.791**            1441                   **611878**    **4.21**    β **-Caryophyllene oxide**
  34       24.383                1455                   54592         0.38        Ethyl chrysanthemate
  35       24.989                1470                   107844        0.74        Isoaromadendrene epoxide
  36       26.576                1510                   78911         0.54        Cubenol
  37       27.128                1524                   143531        0.99        Spathulenol
  38       28.175                1552                   34667         0.24        β-Acoradiene
  39       28.495                1560                   28088         0.19        (-)-Globulol
  40       28.822                1568                   127617        0.88        Longifolenaldehyde
  41       29.291                1580                   258844        1.78        Diepicedren-1-oxide
  42       43.679                1972                   63369         0.44        β-Panasinsene
                                                        14547477      100.00      

Retention index as determined on a RTX5 MS column using the homologous series of

n

-alkanes. The major constituents are represented in bold letters.

AALEO MEDIATES DEATH IN PROMASTIGOTES
-------------------------------------

The anti-proliferative effect of AALEO on promastigotes was studied by monitoring the kinetics of cell growth. AALEO exhibited a time-dependent inhibition in the rate of cell proliferation at a concentration of 100 μg ml^-1^. All the cells appeared dead after 72 h of incubation (**Figure [1A](#F1){ref-type="fig"}**). Pentamidine used as a positive control, showed a similar trend in time-dependent parasite killing. Untreated promastigotes (without any drug) proliferated at a normal rate. Solvent control (0.2% DMSO) showed no adverse effect on the promastigote viability.

![**Anti-promastigote activity of *Artemisia annua* leaves (AALEO).** Log phase *Leishmania donovani* promastigotes were incubated with AALEO (100 μg ml^-1^) for 7 days at 22°C as described in "Materials and Methods." **(A)** Viable parasites enumerated microscopically every day **(B)** promastigote growth reversibility analysis after 4 days of culture, post AALEO withdrawal **(C)** morphological analysis of promastigotes by light microscopy (40×) at 72 h post-treatment and **(D)**% viability ascertained upon incubation of promastigotes for 72 h with increasing concentrations of AALEO (0--100 μg ml^-1^) for IC~50~ determination (inset). Each point or bar corresponds to the mean ± SE of triplicate samples and is representative of one of three independent experiments.](fmicb-05-00626-g001){#F1}

LEISHMANICIDAL ASSAY OF THE TREATED PROMASTIGOTES
-------------------------------------------------

To corroborate the lethal effects of AALEO on promastigotes, treated and untreated parasites after 4 days were washed and re-suspended in fresh media and their viability was determined under phase contrast microscope. After an additional 4 days in culture, the parasites did not revert back to their normal morphology and still appeared dead in case of prior incubation with AALEO, as also observed in positive control (pentamidine), confirming their leishmanicidal effects. Untreated control promastigotes reverted to late log phase (**Figure [1B](#F1){ref-type="fig"}**).

AALEO CAUSES ALTERATIONS IN CELLULAR MORPHOLOGY OF PROMASTIGOTES
----------------------------------------------------------------

Microscopic inspection of promastigotes upon treatment with AALEO (100 μg ml^-1^) revealed that the parasites altered to an ovoid shape with cell shrinkage, loss of flagella, cytoplasmic condensation, resulting in complete circularization of the promastigotes and substantial reduction in size compared to the untreated control. These changes, typical of programmed cell death (PCD; **Figure [1C](#F1){ref-type="fig"}**), were also observed in pentamidine treated parasites.

EVALUATION OF IC~50~ OF AALEO AGAINST *L. donovani* PROMASTIGOTES
-----------------------------------------------------------------

*Artemisia annua* leaves (0--100 μg ml^-1^) treatment demonstrated a dose-dependent killing of the promastigotes and a 50% inhibitory concentration was achieved at 14.63 ± 1.49 μg ml^-1^ (**Figure [1D](#F1){ref-type="fig"}**). The established antileishmanial drug pentamidine, used as a positive control, showed a similar trend in parasite killing. Parasite viability was not affected by DMSO (0.2%, data not shown) used as solvent control.

ANTI-AMASTIGOTE ACTIVITY OF AALEO
---------------------------------

The activity of AALEO on phagocytosed amastigotes within the macrophages was analyzed by microscopic observation of giemsa-stained cells. Macrophages entry by promastigotes involves the formation of membrane bound parasitophorous vacuoles, where they transform into non-motile amastigote form. The parasites survival within the parasitophorous vacuoles determines the pathogenesis. Therefore, it was important to test the activity of AALEO toward the macrophage-resident amastigotes. Treatment with AALEO (0--100 μg ml^-1^) demonstrated a dose-dependent inhibition of amastigote infectivity with IC~50~ of 7.3 ± 1.85 μg ml^-1^ (**Figure [2A](#F2){ref-type="fig"}**). Giemsa-stained micrographs of infected macrophages showed almost total clearance of the intracellular amastigotes at the highest dose (100 μg ml^-1^); similar effect was observed with pentamidine (**Figure [2B](#F2){ref-type="fig"}**).

![**Effect of AALEO on *L. donovani* intracellular amastigote forms.** Promastigote-infested RAW 264.7 macrophages were incubated at 37°C in a CO~2~ incubator with serial fourfold dilutions of AALEO (starting at 100 μg ml^-1^) for 48 h. **(A)**% infectivity estimated for determination of IC~50~ on amastigotes (inset) **(B)** Micrographs of giemsa-stained infected macrophages upon treatment (100×) **(C)** NO generation by uninfected (filled circle) or infected (filled triangle) macrophages post-incubation with AALEO. The dotted and bold dotted lines represent the basal levels of NO produced by uninfected and infected macrophages, respectively. **(D)** Cytotoxicity of AALEO to RAW 264.7 macrophages ascertained as % viability 48 h post-incubation with increasing concentrations of AALEO or pentamidine (0--200 mg ml^-1^). Each point corresponds to the mean ± SE of triplicate samples and is representative of one of three independent experiments.](fmicb-05-00626-g002){#F2}

AALEO INDUCES NITRIC OXIDE PRODUCTION IN *EX VIVO* MODEL
--------------------------------------------------------

Estimation of nitric oxide (NO) in the culture supernatants of murine non-parasitized and parasitized macrophages (RAW 264.7) indicated low basal levels of NO in the parasitized macrophages corroborating with disease progression. Following addition of AALEO (0--100 μg ml^-1^) for 48 h, a dose-dependent increase in NO production occurred in the infected macrophages (**Figure [2C](#F2){ref-type="fig"}**) that was distinctly higher than that released by normal macrophages. AALEO at 100 μg ml^-1^ induced 8.96 ± 1.45 and 16.43 ± 1.68 μM of NO in normal and infected macrophages, respectively.

CYTOTOXICITY OF AALEO ON RAW 264.7 MACROPHAGES CELL LINE
--------------------------------------------------------

*In vitro* cytotoxicity assay was done with the murine macrophage cell line RAW 264.7 to check the adverse effects of AALEO, using pentamidine as a reference drug. The toxicity assay revealed that AALEO had no adverse effects on the viability and morphology of the macrophages (**Figure [2D](#F2){ref-type="fig"}**).

AALEO INDUCES PS EXTERNALIZATION IN *L. donovani* PROMASTIGOTES
---------------------------------------------------------------

During apoptosis in unicellular parasitic cells, PS is translocated from the inner side to the outer leaflet of the plasma membrane. Annexin V, a Ca^2+^-dependent phospholipid binding protein with an affinity for PS, is routinely used to label externalization of PS. Since annexin V can also label necrotic cells, PI was used to differentiate among apoptotic cells (annexin V +ve and PI --ve), necrotic cells (annexin V --ve and PI +ve), late apoptotic cells (annexin V +ve and PI +ve) and live cells (annexin V --ve and PI --ve). In control late log phase promastigotes, the basal binding of annexin V was 9.2%. Whereas, with AALEO, the annexin V binding (a correlate of apoptotic cells) increased to 36.6% and, to 83.7% with pentamidine (**Figures [3A,B](#F3){ref-type="fig"}**). Taken together, our data indicate that AALEO caused apoptosis in promastigotes with externalization of PS.

![**Detection of apoptosis in *L. donovani* promastigotes by annexin V-FITC and PI co-staining.** Parasites were incubated with AALEO or pentamidine (100 μg ml^-1^) for 72 h, and analyzed by flow cytometry as described in the Methods. **(A)** Dual parametric dot plots combining Annexin V-FITC and PI fluorescence, **(B)** % apoptotic cell population. This is a representative profile of three independent experiments.](fmicb-05-00626-g003){#F3}

OLIGONUCLEOSOMAL DNA FRAGMENTATION IN AALEO TREATED PROMASTIGOTES
-----------------------------------------------------------------

One of the important biochemical hallmarks of eukaryotic apoptotic cell death is the fragmentation of nuclear DNA into nucleosomal units. DNA nicking following treatment with AALEO was detected using a TUNEL assay in which the proportion of DNA nicks was quantified by measuring the binding of dUTP--FLUOS to the nicked ends via TdT. Thus, the proportion of DNA nicks was directly proportional to the fluorescence obtained from dUTP--FLUOS. Promastigotes treated with 100 μg ml^-1^ of AALEO for 72 h showed an increase in nuclear DNA fragmentation as evidenced from dUTP--FLUOS binding. The mean fluorescence intensity (MFI) of untreated promastigotes (522) increased to 4694 and 3876 upon treatment with AALEO and pentamidine, respectively (**Figure [4A](#F4){ref-type="fig"}**). The results clearly indicate that AALEO caused DNA nicking in promastigotes.

![***Artemisia annua* leaves treated promastigotes represent TdT-mediated dUTP nick-end labeling (TUNEL) positivity and dyskinetoplastidy.** Exponential phase promastigotes were incubated with AALEO or pentamidine (100 μg ml^-1^) for 72 h. Cells were fixed and stained with dUTP--FITC in the presence of TdT. **(A)** Bar graphs representing MFI of TUNEL expression as analyzed by flow cytometry **(B)** Image acquisition via a fluorescence microscope under 10× objective. **(C)** Treated and untreated parasites were probed with PI for assessment of dyskinetoplastidy and images taken under 20× objective as described in Section "Materials and Methods." N and K represent nuclear and kinetoplast DNA, respectively. Each bar corresponds to the mean ± SE of triplicate samples and is a representative profile of three independent experiments. Images are representative of one of three similar results.](fmicb-05-00626-g004){#F4}

Fluorescence microscopic observation showed the appearance of green fluorescence in treated samples, representing incorporation of dUTP labeled with FLUOS (**Figure [4B](#F4){ref-type="fig"}**). Thus, the results further confirm AALEO-mediated induction of apoptosis in *L. donovani* promastigotes.

AALEO-INDUCED CYTOTOXICITY CAUSES DYSKINETOPLASTIDY IN PROMASTIGOTES
--------------------------------------------------------------------

The kDNA has been shown to be susceptible to elimination (dyskinetoplastidy) by certain DNA intercalating drugs for example, acriXavine and berenil. We observed that AALEO induced genomic DNA fragmentation in *L. donovani* promastigotes. Based on this, we investigated whether AALEO caused any damage to kDNA. Untreated and promastigotes treated with AALEO (100 μg ml^-1^) were permeabilized and stained with PI that binds with DNA of the promastigotes, i.e., kDNA and nuclear DNA. The loss of mitochondrial kDNA was detected at 72 h of treatment with approximately all the cells showing dyskinetoplastic feature (**Figure [4C](#F4){ref-type="fig"}**) against the intact kDNA structure in untreated cells.

AALEO-INDUCED APOPTOSIS CAUSES CELL-CYCLE ARREST IN *L. donovani* PROMASTIGOTES
-------------------------------------------------------------------------------

The changes in cell cycle progression in *L. donovani* promastigotes were examined by flow cytometric analysis of permeabilized and PI stained cells after treatment with AALEO (100 μg ml^-1^) for 72 h. In a given cell, the amount of PI correlates with the DNA content, and accordingly, DNA fragmentation in an apoptotic cell translates into a sub G~0~--G~1~ peak ([@B29]). Promastigotes treated with AALEO caused cell cycle arrest at sub G~0~--G~1~ phase (**Figure [5](#F5){ref-type="fig"}**). The proportion of cells in the sub G~0~--G~1~ phase was 1.69% in the untreated control, which increased to 33.14 and 37.19%, respectively, in the promastigotes treated with AALEO and pentamidine. Thus, the data clearly show that AALEO induced cell cycle arrest at sub G~0~--G~1~ phase.

![***Artemisia annua* leaves induces cell cycle arrest in *L. donovani* promastigotes at sub-G~**0**~--G~**1**~ phase.** After treatment with AALEO and pentamidine (100 μg ml^-1^) for 72 h, the promastigotes were fixed in chilled methanol, probed with PI and the cells acquired using a BD LSR-II flow cytometer for subsequent analysis using Cell Quest software as described in Section "Materials and Methods." Inset shows the cell cycle distribution. This is the representative profile of three independent experiments.](fmicb-05-00626-g005){#F5}

AALEO INDUCES DEPOLARIZATION OF MITOCHONDRIAL MEMBRANE (Ψm)
-----------------------------------------------------------

Alteration of mitochondrial membrane potential (ΔΨm) is a characteristic feature of metazoan apoptosis and has been show to play a key role in drug-induced death in the unicellular protozoan parasites ([@B31]). The loss of ΔΨm was determined using a mito-sensor dye, JC-1. JC-1 is a cationic lipophilic fluorescent dye that freely permeates the mitochondrial membranes and forms J-aggregates in healthy cells, exhibiting pronounced red fluorescence. An apoptotic stimulus induces a decrease in the ΔΨm and JC-1 fails to enter the mitochondria, remaining as cytosolic monomers and emits green fluorescence. Therefore, the ratio of J-aggregates/monomers serve as an effective indicator of the mitochondrial energy state of the parasites, allowing apoptotic cells to be easily distinguished from their non-apoptotic counterparts ([@B40]). In control promastigotes, the red/green fluorescence ratio was 11.9. Treatment with AALEO (100 μg ml^-1^) and pentamidine for 72 h, induced a significant decrease in ΔΨm, resulting in a predominance of JC-1 monomers that fluoresced green, thus, translating into a decrease in the red/green fluorescence ratio to 5.27 and 2.79, respectively (**Figure [6A](#F6){ref-type="fig"}**).

![**Collapse of mitochondrial membrane potential and ROS generation in *L. donovani* promastigotes by AALEO.** Exponential phase promastigotes were incubated with AALEO and pentamidine (100 μg ml^-1^) for 72 h and **(A)** probed with JC-1; bar diagram represents the ratio of red/green fluorescence intensity (MFI) obtained from histogram statistics. **(B)** Histograms depict shift in green fluorescence intensity (FL-1) from left, depicting increased production of ROS in treated promastigotes loaded with H~2~DCFDA. Each bar corresponds to the mean ± SE of triplicate samples and histograms are representative profiles of three independent experiments.](fmicb-05-00626-g006){#F6}

AALEO INDUCES PRO-OXIDANT ACTIVITY IN *L. donovani* PROMASTIGOTES
-----------------------------------------------------------------

To evaluate the effect of AALEO on the oxidative status of promastigotes, H~2~DCFDA, a lipid soluble, membrane permeable compound was used that following cleavage by cellular non-specific esterases, forms an impermeable H~2~DCF, which is subsequently oxidized by intracellular ROS to produce a fluorescent compound, DCF. Therefore, the resultant fluorescence (green) is directly proportional to the quantum of ROS generated. AALEO (100 μg ml^-1^) treatment of promastigotes for 72 h led to significantly enhanced ROS levels with increase in the green fluorescence intensity (FI-1), in comparison to the control untreated parasites as observed by flow cytometry (**Figure [6B](#F6){ref-type="fig"}**).

AALEO ACTIVITY AGAINST *L. donovani IN VIVO*
--------------------------------------------

Treatment of *L. donovani* infected BALB/c mice with AALEO at 50, 100, and 200 mg/kg b.w. resulted in 45.26 ± 8.95, 63.23 ± 7.28, and 88.68 ± 5.52 % parasite reduction, respectively, in the liver, while decrease in the splenic parasite load was more evident, being 72.48 ± 3.88, 80.72 ± 6.61, and 91.66 ± 3.07 %, respectively (**Figure [7A](#F7){ref-type="fig"}**). With AMB, parasite elimination in the liver and spleen was 94.02 ± 1.81 and 98.09 ± 2.44 %, respectively. Compared to the infected controls, a significant reduction in spleen and liver weight was also observed with AALEO (200 mg/kg b.w.) and AMB (**Figure [7C](#F7){ref-type="fig"}**). Morphological observation of spleen in the treated groups also demonstrated reduction in size that was comparable to the naïve group (**Figure [7B](#F7){ref-type="fig"}**).

![**Antileishmanial efficacy of AALEO on established *L. donovani* infection.** Ten weeks infected BALB/c mice were left untreated (INF) or treated for 10 days with PBS (VC), AALEO (50, 100, or 200 mg/kg bw, daily, i.p.) or amphotericin B (AMB; 5 mg/kg bw, alternate days, i.v.) as elaborated in Section "Materials and Methods." Ten days post-treatment **(A)** splenic and hepatic parasite burden (LDU) were determined by stamp smear method, **(B)** morphology of spleen, and **(C)** weights of liver and spleen were also determined. The dotted lines indicate the respective organ weights of naïve mice. Data represent the mean ± SE for five animals per group. Data were tested by ANOVA. Differences between means were assessed for statistical significance by Tukey's test (\*\**P*≤ 0.01; \*\*\**P*≤ 0.001). Results are from one of three representative experiments.](fmicb-05-00626-g007){#F7}

*IN VIVO* TOXICITY STUDIES
--------------------------

Estimation of serum SGOT, SGPT, and ALP for liver dysfunction and urea and creatinine for renal dysfunction, 10 days post injection of AALEO in normal BALB/c mice as well as infected and treated mice demonstrated normal levels of the serum enzymes. AALEO (up to 200 mg/kg b.w.) proved to be non-toxic in BALB/c mice used in antileishmanial screening (**Tables [2A,B](#T2){ref-type="table"}**) indicating no *in vivo* toxicity.

###### 

**(A)** Effect of AALEO on hepatic and renal functions of normal BALB/c mice. **(B)** Effect of AALEO on hepatic and renal functions of infected BALB/c mice post-treatment.

  -------------------------------------------------------------------------------------------------------------------------------- ---------------- ---------------- --------------- ------------------ ------------------------
  **(A)**                                                                                                                                                                                               
  **Group (*n* = 5)**                                                                                                              **SGOT (U/L)**   **SGPT (U/L)**   **ALP (U/L)**   **Urea (mg/dL)**   **Creatinine (mg/dL)**
                                                                                                                                                                                                        
  Control                                                                                                                          52.40 ± 6.18     33.09 ± 10.06    86.14 ± 1.59    18.12 ± 3.17       0.96 ± 0.15
  Essential oils (EO) 200 mg/kg (i.p)                                                                                              53.16 ± 4.56     33.18 ± 4.36     87.18 ± 7.96    16.79 ± 4.91       0.84 ± 0.08
                                                                                                                                                                                                        
  *Mice (*n* = 5) received EO daily for 10 consecutive days. Enzymatic estimations (mean ± SE) were done using commercial kits.*                                                                        
                                                                                                                                                                                                        
  **(B)**                                                                                                                                                                                               
  **Group (*n* = 5)**                                                                                                              **SGOT (U/L)**   **SGPT (U/L)**   **ALP (U/L)**   **Urea (mg/dL)**   **Creatinine (mg/dL)**
                                                                                                                                                                                                        
  Infected control                                                                                                                 48.40 ± 5.58     29.78 ± 3.77     89.42 ± 3.8     15.86 ± 2.60       1.16 ± 0.39
  AmB 5 mg/kg (i.v)                                                                                                                53.93 ± 2.78     38.10 ± 1.16     85.36 ± 1.7     18.19 ± 1.90       0.99 ± 0.14
  EO 50 mg/kg (i.p)                                                                                                                45.60 ± 5.39     29.99 ± 5.62     83.19 ± 2.9     16.24 ± 0.96       0.89 ± 0.11
  EO 100 mg/kg (i.p)                                                                                                               42.43 ± 4.29     33.21 ± 3.07     87.31 ± 11.6    18.96 ± 1.93       1.00 ± 0.16
  EO 200 mg/kg (i.p)                                                                                                               51.60 ± 0.56     31.78 ± 3.36     84.18 ± 5.9     17.49 ± 1.69       1.09 ± 0.10
  -------------------------------------------------------------------------------------------------------------------------------- ---------------- ---------------- --------------- ------------------ ------------------------

Mice (

n

= 5) received EO daily for 10 consecutive days. Enzyme estimations (mean ± SE) were done using commercial kits.

DISCUSSION
==========

Natural products, especially EO from the aromatic herbs, have shown a wide spectrum of biological activities including antifungal ([@B12]) antibacterial ([@B32]) and antiprotozoal ([@B13]) among others. Plant EO and active components can be used as alternatives or adjunct to current antiparasitic therapies. Leishmanicidal activity of EO has recently been documented ([@B23]; [@B27]) such as linalool-rich essential oil from leaves of *Croton cajucara* ([@B24]), eugenol-rich essential oil from *Ocimum gratissimum* ([@B38]) and sesquiterpenes-rich essential oil from *Eugenia uniflora* ([@B23]) that have been shown to be cytotoxic against *L*. *amazonensis* parasites. EO from *A. herba-alba* and *A. annua* have been reported to exhibit antifungal, and antibacterial activities ([@B11]). In the present study, we reported antileishmanial activity of the essential oil from AALEO. The essential oil of *A. absinthium,* having oxygenated monoterpene camphor as the major constituent has been reported to exhibit activity against the promastigotes and amastigote forms of *L. aethiopica* and *L. donovani* ([@B36]). Our findings are in agreement with these studies as the GC-MS analysis of AALEO revealed significantly higher content of camphor (52.06%) followed by β-caryophyllene (10.95%).

The camphor-rich essential oil of *A. annua* exhibited a dose-dependent significant antileishmanial effect against the promastigotes as well as the intracellular amastigotes of *L. donovani*. The effect was leishmanicidal as evidenced by growth reversibility analysis and alterations in cellular morphology including shrinkage in the promastigotes that became round in shape with disrupted flagella and had no motility.

The leishmanicidal activities of the plant secondary metabolites such as curcumin ([@B3]), racemoside A ([@B6]), artemisinin ([@B31]), *Aloe vera* leaf exudates ([@B7]), and ethanolic extract of leaves of *Piper betle* ([@B29]) have been reported to be mediated by apoptosis. *Leishmania* parasites can undergo PCD in response to natural compounds and EO ([@B6]; [@B31]; [@B3]; [@B15]; [@B10]). The mode of cell-death caused by AALEO was further investigated, since to the best of our knowledge, no such study on AALEO or camphor has been reported earlier.

During PCD in unicellular parasites, PS is externalized from the inner to the outer surface of the plasma membrane. In our studies, AALEO-treated *L. donovani* promastigotes also caused PS exposures at a significant rate as evidenced by the increased annexin V binding. The changes occurring in the nuclear material during PCD were further characterized. *In situ* TUNEL of nicked DNA was observed with AALEO thus, strongly substantiating apoptosis in *L. donovani* promastigotes. This has also been evidenced with essential oil from *Piper betle* and *Syzygium aromaticum* ([@B15]; [@B10]).

DNA fragmentation in an apoptotic cell translates into a sub G~0~--G~1~ peak. Cell cycle analysis with PI showed a significant increase in the proportion of cells in the sub G~0~--G~1~ phase when treated with AALEO. This confirmed that the apoptotic cell was arrested at the sub G~0~--G~1~ phase. Similar observation has been reported with other natural antileishmanial molecules such as curcumin, artemisinin and berberine chloride, wherein, a substantial population of cells have been identified in the sub G~0~--G~1~ phase ([@B31]; [@B3]; [@B26]; [@B10]).

The mitochondria of the parasites seem to be central to the cytotoxic action of different natural and synthetic molecules such as pentamidine, miltefosine, and essential oil of *S. aromaticum* that have caused dyskinetoplastidy in *L. donovani* promastigotes ([@B40]; [@B10]). In the present study, we found that the AALEO-induced leishmanicidal effect was accompanied by dyskinetoplastidy as evidenced by PI staining, corroborating the earlier studies.

Permeabilization of the outer and inner mitochondrial membranes can lead to cell death by apoptosis or necrosis. The loss of mitochondrial membrane potential (ΔΨm) is generally an early change associated with apoptosis as the dissipation of ΔΨm following permeabilization of the inner mitochondrial membrane triggers the release of several apoptotic factors. Artemisinin, berberine chloride, racemoside A, *Piper betle*, and essential oil of *S. aromaticum* have been reported to demonstrate leishmanicidal activity that was associated with a loss in ΔΨm ([@B6]; [@B31]; [@B15]; [@B26]). In our studies, AALEO too caused mitochondrial membrane depolarization.

In multicellular and unicellular organisms, the mitochondria serve as an important cellular source for generation of ROS and reactive nitrogen species (RNS), critical for induction of apoptosis. The production of ROS during early phase of apoptosis usually follows an imbalance in the cellular redox homeostasis. Withaferin A, curcumin, ethanolic extracts of *Piper betle* and eugenol-rich essential oil from *S. aromaticum* ([@B6]; [@B3]; [@B15]; [@B10]) have been reported to induce apoptosis by generating ROS in promastigotes. This prompted us to evaluate whether AALEO could elicit oxidative stress in *L. donovani*. In our study, we found that AALEO triggered the production of ROS within the promastigotes that might have contributed to their apoptotic death. NO intermediates have earlier been reported to intercede antileishmanial effect by *Kalanchoe pinnata* ([@B4]). NO has also been reported to cause extensive fragmentation of nuclear DNA in both axenic and intracellular amastigotes of *L. amazonensis* ([@B9]). Our studies are in agreement with the previous reports as a significant increase in NO was observed after exposure of amastigote-infected macrophages to AALEO. Generation of NO following drug treatment in infected macrophages further indicated the involvement of RNS in amastigote death. EO from *Ocimum gratissimum* ([@B38]) and *Croton cajucara* ([@B5]) have shown similar NO enhancing activities.

We further explored the therapeutic efficacy of AALEO against VL using *L. donovani* infected BALB/c mice. The major findings emerging from this study are that AALEO (200 mg/kg b.w) resulted in maximum clearance of parasites (88--91%) from the liver and spleen of mice with established *L. donovani* infection as compared to untreated infected controls. Significant reduction in spleen and liver weight was also observed with AALEO. Similar therapeutic effect has been reported with the essential oil of *Chenopodium ambrosioides* ([@B18]) and *Bixa orellana* ([@B17]).

The hepatic and renal toxicities in normal and *L. donovani* infected BALB/c mice upon subsequent administration of AALEO (upto 200 mg/kg b.w.) were evaluated by monitoring the serum levels of SGOT, SGPT, ALP, urea, and creatinine. The enzymatic levels were in the normal range, indicating preclusion of hepato- and nephro-toxicity. In *ex vivo* studies also, AALEO was not found to compromise the macrophage viability.

Thus, we conclusively demonstrate that camphor-rich oil of AALEO exhibited antileishmanial efficacy against the promastigotes and intracellular amastigotes. The leishmanicidal activity was further confirmed in *L. donovani* infected BALB/c mice where ≥90% inhibition of parasite burden was observed. The leishmanicidal effect was mediated by PCD as evidenced by PS externalization, *in situ* DNA nicking, dyskinetoplastidy, cell cycle arrest at sub- G~0~--G~1~ phase, reduction of ΔΨm, ROS, and RNI generation (**Figure [8](#F8){ref-type="fig"}**). Moreover, no cytotoxic effect was observed on the mammalian macrophages and there was no impairment of liver and kidney functions of BALB/c mice treated with AALEO. Our study widens the scope for future designing and strengthening of the chemotherapeutic strategies for better management of this debilitating disease.

![**Proposed model for AALEO-induced PCD in *L. donovani* promastigotes and amastigotes**.](fmicb-05-00626-g008){#F8}
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